Urethral Stricture Treatment Devices Market By Product Type (Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, And Urinary Catheters), By Stricture Location (Anterior And Posterior), By End User (Hospitals, Specialty Clinics, And Others), and by geography is expected to grow at a steady CAGR (forecast period- 2021–2026) owing to increase in probability of urethral stricture formation as a complication of cancer treatment for prostate and colorectal cancers as well as extensive use of urinary catheters.
Global urethral stricture treatment devices market was valued at USD 1.38 billion in 2020, growing at a CAGR of 7.10% during the forecast period from 2021 to 2026 to reach USD 2.08 billion by 2026. The demand for urethral stricture treatment devices is witnessing a surge majorly due to the rising prevalence of cancers in the pelvic region such as colorectal and prostate cancers wherein the cancer treatment is linked with increased probability of urethral stricture formation, growing prevalence of benign prostatic hyperplasia in which urethral stricture may form as a complication of surgical interventions, increasing geriatric population wherein aging plays a major role in the development of numerous diseases such as neurogenic bladder leading to the development of urethral strictures sue to extensive use of urinary catheters, and advancements in product development such as drug-eluting urology balloon thereby boosting the growth of the urethral stricture treatment devices market during the forecast period from 2021–2026.
